NNGRF
Price:
$12.7582
Market Cap:
$19.24M
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare line products; point of care testing products for hospitals and medical practices for detection of HIV, human cardiac Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of bioma...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-03-02
Stock Exchange
OTC
Ticker
NNGRF
According to NanoRepro AG’s latest financial reports and current stock price. The company's current ROE is -5.30%. This represents a change of 28.32% compared to the average of -4.13% of the last 4 quarters.
The mean historical ROE of NanoRepro AG over the last ten years is -7.31%. The current -5.30% ROE has changed -27.45% with respect to the historical average. Over the past ten years (40 quarters), NNGRF's ROE was at its highest in in the June 2021 quarter at 48.17%. The ROE was at its lowest in in the December 2009 quarter at -108.34%.
Average
-7.31%
Median
-9.73%
Minimum
-51.70%
Maximum
51.59%
Discovering the peaks and valleys of NanoRepro AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.55%
Maximum Annual ROE = 51.59%
Minimum Annual Increase = -179.05%
Minimum Annual ROE = -51.70%
| Year | ROE | Change |
|---|---|---|
| 2024 | -5.36% | -53.78% |
| 2023 | -11.60% | 47.80% |
| 2022 | -7.85% | -115.22% |
| 2021 | 51.59% | 143.22% |
| 2020 | 21.21% | -179.05% |
| 2019 | -26.84% | 420.53% |
| 2018 | -5.16% | -73.14% |
| 2017 | -19.20% | 5.60% |
| 2016 | -18.18% | -64.84% |
| 2015 | -51.70% | 3.55% |
The current ROE of NanoRepro AG (NNGRF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.27%
5-year avg
9.60%
10-year avg
-7.31%
NanoRepro AG’s ROE is less than ACS Global, Inc. (0%), greater than Broncus Holding Corporation (-9.19%), less than EKF Diagnostics Holdings plc (8.50%), less than Adocia S.A. (180.00%), greater than Diaceutics PLC (-3.94%), less than Recce Pharmaceuticals Ltd (533.12%), greater than Volpara Health Technologies Limited (-17.60%), greater than Creso Pharma Limited (-130.99%), greater than AnGes, Inc. (-369.09%), less than Cell MedX Corp. (65.20%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $171.27M | |
| -9.19% | $42.11M | |
| 8.50% | $179.63M | |
| 180.00% | $170.44M | |
| -3.94% | $115.56M | |
| 533.12% | $76.55M | |
| -17.60% | $188.24M | |
| -130.99% | $131.72M | |
| -369.09% | $139.07M | |
| 65.20% | $126.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoRepro AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoRepro AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NanoRepro AG's ROE?
How is the ROE calculated for NanoRepro AG (NNGRF)?
What is the highest ROE for NanoRepro AG (NNGRF)?
What is the 3-year average ROE for NanoRepro AG (NNGRF)?
What is the 5-year average ROE for NanoRepro AG (NNGRF)?
How does the current ROE for NanoRepro AG (NNGRF) compare to its historical average?